Skip to main content

Phase 1/2 Open label study of SL-401 with Pom/Dex in R/R MM

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Stemline Therapeutics, Inc

Start Date

May 1, 2016

End Date

April 30, 2021
 

Administered By

Duke Cancer Institute

Awarded By

Stemline Therapeutics, Inc

Start Date

May 1, 2016

End Date

April 30, 2021